Patents by Inventor Barbara Schlingmann

Barbara Schlingmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for managing respiratory conditions
    Patent number: 10919934
    Abstract: This disclosure relates to compositions for use in managing respiratory distress and related disorders. In certain embodiments, the disclosure relates to methods of treating or preventing respiratory distress comprising administering an effective amount of a pharmaceutical composition comprising peptides or agents disclosed herein to a subject in need thereof. In certain embodiments, the peptides or agents decrease the concentration of claudin-5 in cells and tissues of the lungs.
    Type: Grant
    Filed: July 7, 2020
    Date of Patent: February 16, 2021
    Assignee: Emory University
    Inventors: Michael Koval, Barbara Schlingmann
  • Compositions and Methods for Managing Respiratory Conditions
    Publication number: 20200331965
    Abstract: This disclosure relates to compositions for use in managing respiratory distress and related disorders. In certain embodiments, the disclosure relates to methods of treating or preventing respiratory distress comprising administering an effective amount of a pharmaceutical composition comprising peptides or agents disclosed herein to a subject in need thereof. In certain embodiments, the peptides or agents decrease the concentration of claudin-5 in cells and tissues of the lungs.
    Type: Application
    Filed: July 7, 2020
    Publication date: October 22, 2020
    Inventors: Michael Koval, Barbara Schlingmann
  • Compositions and methods for managing respiratory conditions
    Patent number: 10738079
    Abstract: This disclosure relates to compositions for use in managing respiratory distress and related disorders. In certain embodiments, the disclosure relates to methods of treating or preventing respiratory distress comprising administering an effective amount of a pharmaceutical composition comprising peptides or agents disclosed herein to a subject in need thereof. In certain embodiments, the peptides or agents decrease the concentration of claudin-5 in cells and tissues of the lungs.
    Type: Grant
    Filed: April 13, 2018
    Date of Patent: August 11, 2020
    Assignee: Emory University
    Inventors: Michael Koval, Barbara Schlingmann
  • Compositions and Methods for Managing Respiratory Conditions
    Publication number: 20180298057
    Abstract: This disclosure relates to compositions for use in managing respiratory distress and related disorders. In certain embodiments, the disclosure relates to methods of treating or preventing respiratory distress comprising administering an effective amount of a pharmaceutical composition comprising peptides or agents disclosed herein to a subject in need thereof. In certain embodiments, the peptides or agents decrease the concentration of claudin-5 in cells and tissues of the lungs.
    Type: Application
    Filed: April 13, 2018
    Publication date: October 18, 2018
    Inventors: Michael Koval, Barbara Schlingmann